Trial
NCT04853498
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Collaborators
—
Condition
Metastatic Castration-resistant Prostate Cancer
Intervention
TQB3720
Why stopped
Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-31